Back to PE Pentwater Capital Management LP
APGE
2 quarters
Position history for PEPentwater Capital Management LP's holdings in APOGEE THERAPEUTICS INC
As of its Q2 2026 13F, Pentwater Capital Management held 1,425,000 shares of APGE (Apogee Therapeutics), worth $189.1M. APGE was 1.2% of Pentwater Capital Management's reported 13F portfolio.
Final Value
$0
Final Shares
0
Total Value Change
-$189.1M
Total Shares Change
-1.4M
Quarter-by-Quarter History